Health
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study – Times of India
India News: Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant…
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
- News
- India News
- Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
Continue Reading
